Cross Staff Investments Inc Bristol Myers Squibb CO Transaction History
Cross Staff Investments Inc
- $117 Million
- Q2 2024
A detailed history of Cross Staff Investments Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cross Staff Investments Inc holds 7,155 shares of BMY stock, worth $370,271. This represents 0.25% of its overall portfolio holdings.
Number of Shares
7,155
Previous 7,146
0.13%
Holding current value
$370,271
Previous $387,000
23.26%
% of portfolio
0.25%
Previous 0.34%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,402Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.66 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.21 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.73 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.86 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.06 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $110B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...